ABSTRACT:
Betulinic acid, a triterpenoid, is currently a molecule of great research interest with significant pharmacological activities including antioxidant action. In the current study we decided to study the effect of betulinic acid in a rat model of gentamicin induced renal damage. Nephrotoxicity was induced with gentamicin 80mg/kg, intraperitoneally for 8 days, and the test drug was administered at doses, 0.5, 1.5, and 3 mg/kg, per oral for 8 days, betulinic acid administered 3 days prior and concurrently with gentamicin for 5 days in wistar albino rats. Biochemical parameters studied included blood urea, serum creatinine, uric acid and blood urea nitrogen and also corroborated with histopathological examination of the kidney. The control group treated with gentamicin showed marked renotoxicity as evidenced by raised serum urea, serum uric acid, serum creatinine and blood urea nitrogen (107.5±16.92 mg/dL, 0.88±0.09 mg/dL, 3.05±0.29 mg/dL and 47.80±9.07 mg/dL resp.) when compared to the saline treated groups. Betulinic acid when given with gentamicin significantly (p < 0.05) decreased the biochemical parameters. Histopathological study revealed dilated tubules, denuded epithelium and extensive tubular necrosis in the disease control, whereas betulinic acid in higher doses showed evidence of renal tubular regeneration. To conclude, the results of the present study indicates that betulinic acid has significant nephroprotective effect in animal models of gentamicin induced renal damage.
REFERENCES:
1.
Swain RA, Kaplan-Machlis B. Therapeutic uses of vitamin E in prevention of
atherosclerosis. Alternative Medicine Review. 1999; 4:414–23.
2. Mingeot-Leclercq MP, Tulkens PM. Aminoglycoside Nephrotoxicity.
Antimicrobial Agents and Chemotherapy. 1999; 43:1003-12.
3. Begg EJ, Barclay ML. Aminoglycosides – 50 years. British
Journal of Clinical Pharmacology. 1995; 39(6): 597-603.
4. Edson RS, Terrel CL. The Aminoglycosides. Mayo Clinic
Proceedings. 1999; 74: 519-28.
5. Khoory BJ, Fanos V, Dall AA, Cataldi L.
Aminoglycosides, risk factors and neonatal kidney. La
Pediatria Medica e Chirurgica 1996; 18: 495-99.
6. Rougier F, Claude D, Maurin M, Maire P. Aminoglycoside
Nephrotoxicity. Current Drug Targets- Infectious Disorders. 2004; 4: 153-62.
7. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R,
Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D.A role for superoxide in gentamicin-mediated nephropathy in rats. European
Journal of Pharmacology. 2002; 450:67–76.
8. Al-Majed A, Mostafa AM, Al-Rikabi AC, Al-Shabanah O.
Protective effects of oral Arabic gum administration on gentamicin
nephrotoxicity in rats. Pharmacological Research. 2002; 46: 445–51.
9. Reiter RJ, Tan D, Sainz RM, Mayo JC, Lopez-Burillo S.
Melatonin: reducing the toxicity and increasing the efficacy of drugs. Journal of
Pharmacy and Pharmacology. 2002; 54:1299–321.
10. Halliwell B, Gutteridge JMC. Free radicals in biology and
medicine. Oxford: Clarendon Press 1999.
11. Kumar KV, Naidu MUR, Shifow A A, Ratnakar KS. Probucol
protects against gentamicin-induced nephrotoxicity in rats. Indian. Journal of
Pharmacology. 2000; 32:108-113.
12. Abdel-Raheem IT, Abdhal-Ghany AA, Mohamed GA. Protective
effects of Quercetin against gentamicin-induced nephrotoxicity in rats. Biological
and Pharmaceutical Bulletin. 2009; 32 (1): 61-67.
13. Yaman I, Balikci E. Protective effects of nigella
sativa against gentamicin-indeced nephrotoxicity in rats. Experimental and Toxicologic Pathology. 2010; 62: 183-190.
14. Harlalka GV, Patil CR, Patil MR. Protective effecs of
Kalanchoe pinnata pers. (Crassulaceae) on gentamicin-induced nephrotoxicity in
rats. Indian. Journal of Pharmacology 2007;39 (4): 201-205.
15. Lee SY, Kim HH, U Park S. Recent studies on betulinic
acid and its biological and pharmacological activity. Experimental and Clinical Sciences,
International Online Journal. 2015; 14:199-203.
16. Mukherjee R, Kumar V, Srivastava SK, Agarwal SK,
Burman AC. Betulinic acid derivatives as anticancer agents: structure activity
relationship. Anticancer Agents in Medicinal Chemistry. 2006; 6:271-9.
17. J.L. Simonsen, W.C.J.
Ross. The Terpenes, vol. 4, University Press Cambridge (1957) 289.
18. Patocka J. Biologically active pentacyclic triterpenes
and their current medicine signification. Journal
of Applied Biomedicine. 2003;
1:7-12.
19. Yogeeswari P, Sriram D. Betulinic acid and its
derivatives: a review on their biological properties. Current Medicinal Chemistry.
2005; 12:657-66
20. Gheorgheosu D, Duicu O, Dehelean C, Soica C, Muntean
D. Betulinic acid as a potent and complex antitumor phytochemical: a
minireview. Anticancer Agents in Medicinal Chemistry. 2014; 14:936-45.
21. Peng J,
Lv YC,
He PP,
Tang YY,
Xie W,
Liu XY,
Li Y,
Lan G,
Zhang M,
Zhang C,
Shi JF,
Zheng X,
Yin WD,
Tang CK.
Betulinic acid downregulates expression of oxidative stress-induced lipoprotein
lipase via the PKC/ERK/c-Fos pathway in RAW264.7 macrophages. Biochimie. 2015; 119:192-203.
22. Onwuchekwa C, Oluwole FS. Anti-gastric ulcer and
antiinflammatory properties of
betulinic acid in male albino rats. Science World Journal. 2010; 5(4):15-7.
23. Qadir, Irfan and Tahir, Mohammad and Lone, Khalid and
Munir, Bushra and Sami, Waqas. Gentamicin induced nephrotoxicity in albino mice.
Biomedica. 2010; 26:162-165.
24. Martínez-Salgado, C.; Henández-López, F. J. and Novoa-
López, J. M. Glomerular nephrotoxicity of aminoglycosides. Toxicology and Applied Pharmacology.
2007; 223(1):86- 98.
25. De Souza,VB, Oliveira RF,
Lucena HF, Ferreira AAA, Guerra GCB, Freitas ML, Queiroz KCS and De Araujo
Junior RF. Gentamicin induces renal
morphopathology in Wistar rats. International Journal of Morphology. 2009;
27(1):59-63.
26. Jedage H. D. Pharmacognostic,
Phytochemical investigation and Pharmacological evaluation of Scoparia Dulcis Linn. plant extracts for
nephroprotective activity. International Journal of Pharmaceutical Science
and Research.
2014;
5(8): 3342-3346.
27.
Maldonado
PD, Barrera D, Rivero I, Mata R, Medina-Campos ON, Hernandez-Pando R, et al.
Antioxidant sallylcysteine prevents gentamicin-induced oxidative stress and
renal damage. Free Radical Biology and Medicine. 2003; 35:317–324.
28. Walker PD, Barri Y, Shah SV. Oxidant mechanisms in
gentamicin nephrotoxicity. Renal Failure. 1999; 21:433–442.
29. Zorov DB. Amelioration of aminoglycoside
nephrotoxicity requires protection of renal mitochondria. Kidney
International. 2010;
77:841–843.
30. Sahu BD, Kuncha M, Putcha UK, et al. Effect of
metformin against cisplatin induced acute renal injury in rats: a biochemical
and histoarchitectural evaluation. Experimental and Toxicologic Pathology. 2013; 65:933–940.
31. S. Chanda and R. Dave In vitro models for antioxidant
activity evaluation and some medicinal plants possessing antioxidant
properties: An overview. African Journal
of Microbiology Research. 2009;
3(13):981-996.
32. Yi J, Xia W, Wu J, Yuan L, Wu J, Tu D, et al.
Betulinic acid prevents alcohol-induced liver damage by improving the
antioxidant system in mice. Journal of Veterinary Science. 2014; 15:141-8.
33. Kaur R, Arora S. Interactions of betulinic acid with
xenobiotic metabolizing and antioxidative enzymes in DMBA-treated Sprague
Dawley female rats. Free Radical Biology and Medicine. 2013; 65:131-42
34. Nader MA, Baraka HN. Effect of betulinic acid on
neutrophil recruitment and inflammatory mediator expression in
lipopolysaccharide-induced lung inflammation in rats. European Journal of Pharmaceutical Science. 2012; 46:106-13.
35. D. Beauchamp, G. Laurent, L. Grenier et al., Attenuation
of gentamicin-induced nephrotoxicity in rats by fleroxacin, Antimicrobial Agents and Chemotherapy. 1997; 41(6):1237–1245.